<DOC>
	<DOCNO>NCT01046942</DOCNO>
	<brief_summary>The purpose study determine whether add clopidogrel aspirin coronary bypass operation ( CABG ) improve graft patency , patient preoperatively increased platelet activity ( hypercoagulable ) therefore great risk graft occlusion ( thrombosis ) .</brief_summary>
	<brief_title>ThrombElastoGraphic Haemostatic Status Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery</brief_title>
	<detailed_description>Graft patency CABG report 80-90 % worldwide 1 year follow surgery . In immediate period surgery , follow month , graft occlusion mainly occur due thrombosis . Patients platelet hyperreactivity increase risk thromboembolic event , include graft occlusion , myocardial infarction stroke . Therefore intensify antiplatelet therapy patient , must anticipate beneficial effect . Hypercoagulable patient identify thrombelastography ( TEG ) Maximal Amplitude ( MA ) &gt; 69 , thereafter randomize either clopidogrel ( 3months ) aspirin aspirin alone . At 3 month postoperative surgery coronary graft patency assess Multislice CT scan . Pre- postoperatively , 3month followup , TEG multiplate aggregometry perform assess platelet reactivity resistance aspirin clopidogrel .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Thrombophilia</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Hemostatics</mesh_term>
	<criteria>Elective/subacute multivessel CABG Isolated CABG procedure , concomitant surgery age &gt; 18 year Able give inform consent Myocardial infarction &lt; 48h surgery Prior CABG surgery within 1 month Cardiac Shock within 48h surgery Atrial fibrillation Anticoagulation therapy VKA ICH/TCI within 30 day Prior peptic ulcerÂ· Platelet count &lt; 150 E9 Ongoing bleed Known platelet disease Allergic aspirin clopidogrel Liver disease elevate ALAT/ASAT &gt; 1,5x normal Creatinine &gt; 0,120mmol/l Contrast allergy Alcohol narcotic abuse Pregnancy Not able give inform consent Geographically available follow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Saphenous vein</keyword>
	<keyword>Antiplatelet therapy</keyword>
	<keyword>Hypercoagulable</keyword>
	<keyword>Clopidogrel resistance</keyword>
	<keyword>Aspirin resistance</keyword>
	<keyword>Clopidogrel</keyword>
	<keyword>Aspirin</keyword>
	<keyword>Saphenous vein graft disease</keyword>
	<keyword>TEG</keyword>
	<keyword>Thrombelastography</keyword>
	<keyword>Multiplate aggregometry</keyword>
	<keyword>Multislice CT</keyword>
	<keyword>Coronary artery bypass graft surgery</keyword>
	<keyword>coagulation status</keyword>
	<keyword>graft patency</keyword>
	<keyword>CABG</keyword>
</DOC>